Gary Calandra
Keine laufenden Positionen mehr
Profil
Dr. Calandra joined AnorMED in September 2000 and is responsible for leading and directing the Company’s clinical research activities.
Dr. Calandra has over 20 years of clinical trial experience in the areas of infectious and inflammatory disease.
He was formerly the Vice-President Clinical Development at Pasteur Merieux Connaught in Swiftwater, Pennsylvania and prior to that was Senior Director, Clinical Research at the Merck Research Laboratories in West Point, Pennsylvania.
While at Merck, one of Dr. Calandra's areas of responsibility was the development of Crixivan for HIV infection
Ehemalige bekannte Positionen von Gary Calandra
| Unternehmen | Position | Ende |
|---|---|---|
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Corporate Officer/Principal | 09.11.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
